Back to search

The Open University

Impact of branched-chain amino acids in triple-negative breast cancer treatment

Abstract

dc:description.abstract

Triple-negative Breast Cancer (TNBC) represents the most aggressive breast cancer subtype, with few effective therapeutic options in the metastatic stage. Calorie-restricted approaches, such as cyclic fasting or fasting-mimicking diet (FMD), showed promising antitumor effects in murine TNBC models and TNBC patients. Our group recently found that cyclic FMD causes an increase in plasma levels of the branched-chain amino acids (BCAAs). However, the impact of BCAAs on TNBC growth is poorly explored. Here I show that the supplementation of an excess of extracellular BCAAs, and in particular of leucine and isoleucine, displays antiproliferative effects in several in vitro TNBC models by slowing down cell cycle progression and inducing senescence. These effects were also replicated in vivo. TNBC cells expressing higher levels of the Branched Chain Aminotransferase 1 (BCAT1) enzyme degrade intracellular BCAAs more efficiently, thus resulting in reduced antiproliferative effects. Notably, BCAT1 downregulation sensitizes BCAA-resistant cells to BCAA supplementation. Therefore, BCAT1 can be considered a biomarker predicting cancer cell sensitivity to BCAA supplementation. BCAA antiproliferative effects in part result from the competition of extracellular BCAAs with essential amino acids (EAAs) that are uptaken through the same plasma membrane transporters. The competition of an excess of BCAAs with physiological levels of extracellular EAAs results in a shortage of intracellular EAAs which, in turn, causes the inhibition of mTORC1, polysome elongation, and protein synthesis. Finally, combining BCAA supplementation with anthracycline, paclitaxel, or especially with carboplatin resulted in cooperative antitumor effects, thus revealing the translational potential of BCAA supplementation in TNBC patients.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
The Open University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Cantarelli, Beatrice

Rights

Language dc:language
en

Chain of custody

source
Harvested from
The Open University
Base URL
oro.open.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Cantarelli, Beatrice. Impact of branched-chain amino acids in triple-negative breast cancer treatment. doctoral thesis, The Open University, 2025.